Although is clear that the TFE3 fusion is the defining alteration in tRCC, the specific mechanism(s) by which it drives oncogenesis remain obscure. The gene discussed is TFE3; the disease is renal cell carcinoma associated with Xp11.2 translocations/TFE3 gene fusions.